Neoadjuvant Adebrelimab in Resectable SCLC: A Randomized Trial

Clinical trial NCT06485544 · RECRUITING

Trial details

NCT number: NCT06485544
Sponsor: Tang-Du Hospital
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Small Cell Lung Cancer (SCLC)

Start date: 2024-07-01
Primary completion: 2025-12-30
Enrollment: 104

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.